TNFRSF10B and familial pancreatic carcinoma: DR5 shows low or no expression in normal cells; however, it is highly expressed in various cancers, including lymphocytic leukemia, lymphoma, multiple myeloma, lung carcinoma, colon cancer, breast cancer, ovarian cancer, bladder cancer, and pancreatic cancer [14, 15].